UN Security Council
2015

well as to enable effective and sustainable nuclear security and physical protection systems. E. Nuclear Medicine and Radioisotopes, Associated Technologies, Facilities and Processes 11. E3/EU+3 parties, as appropriate, are prepared to cooperate with Iran to improve the utilization of nuclear medicine in Iran in order to enhance Iran’s expertise in diagnostic imaging and radiotherapy, increase the availability of medical radioisotopes for diagnosis and treatment of Iranian citizens, and facilitate Iran’s participation in the broader international scientific and nuclear medicine community. Such cooperation may include: 11.1. Upgrades to the infrastructure associated with existing cyclotron facilities, including for medical radioisotopes production. 15-12243 85/104 S/RES/2231 (2015) 11.2. Facilitating Iranian acquisition of a new cyclotron, and associated radio - pharmacy equipment, for medical radioisotopes production. 11.3. Acquisition of state-of-the-art diagnostic imaging and radiotherapy equipment for existing or new nuclear medicine centers, including co -operation between hospitals for the treatment of individual patients. 11.4. Cooperation on occupational and patient dosimetry procedures. 11.5. Improved target utilization to increase radioisotope production. 11.6. Acquisition of radioisotope sources for bracho therapy, and radiotherapy